Invention Grant
- Patent Title: Synthesis methods for upadacitinib and intermediate thereof
-
Application No.: US17272369Application Date: 2019-08-26
-
Publication No.: US11926633B2Publication Date: 2024-03-12
- Inventor: Peng Wang , Pixu Li , Qiang Wei , Wen Cheng , Hao Wu
- Applicant: SUZHOU PENGXU PHARMATECH CO., LTD
- Applicant Address: CN Suzhou
- Assignee: SUZHOU PENGXU PHARMATECH CO., LTD
- Current Assignee: SUZHOU PENGXU PHARMATECH CO., LTD
- Current Assignee Address: CN Suzhou
- Priority: CN 1811008444.4 2018.08.31 CN 1811083531.6 2018.09.17
- International Application: PCT/CN2019/102443 2019.08.26
- International Announcement: WO2020/043033A 2020.03.05
- Date entered country: 2021-03-01
- Main IPC: C07D487/14
- IPC: C07D487/14 ; C07D207/08 ; C07D207/16 ; C07D241/20 ; C07D487/04

Abstract:
The present disclosure relates to a JAK inhibitor upadacitinib intermediate and a preparation method therefor, and to a preparation method for a JAK inhibitor upadacitinib. The upadacitinib intermediate of the present application is as shown in Formula (II) or Formula (III),
wherein, R is a protective group of nitrogen atoms, and R1 is an open-chain or cyclic amine group. Compared with the prior art, the method for the synthesis of upadacitinib of the present application, significantly reduces cost, is environmentally-friendly. And the quality of the final product is well controlled.
wherein, R is a protective group of nitrogen atoms, and R1 is an open-chain or cyclic amine group. Compared with the prior art, the method for the synthesis of upadacitinib of the present application, significantly reduces cost, is environmentally-friendly. And the quality of the final product is well controlled.
Public/Granted literature
- US20210323971A1 SYNTHESIS METHODS FOR UPADACITINIB AND INTERMEDIATE THEREOF Public/Granted day:2021-10-21
Information query